Department of General Surgery, Royal Stoke University Hospital, Stoke-On-Trent, UK.
Department of General Surgery, University Hospital of Wales, Cardiff, UK.
Curr Obes Rep. 2023 Sep;12(3):395-405. doi: 10.1007/s13679-023-00521-4. Epub 2023 Aug 3.
To evaluate the incidence of long-term de novo acid reflux-related complications following sleeve gastrectomy (SG) to determine whether routine postoperative surveillance endoscopy is necessary.
A systematic search of Medline, Embase, CINAHL, CENTRAL, the Web of Science, and bibliographic reference lists was conducted. A proportion meta-analysis model was constructed to quantify the risk of the de novo gastro-oesophageal reflux disease (GORD), oesophagitis, and Barrett's oesophagus (BE) at least 4 years after SG. Random-effects modelling was applied to calculate pooled outcome data.
Thirty-two observational studies were included reporting a total of 7904 patients who underwent primary SG and were followed up for at least 4 years. The median follow-up period was 60 months (48-132). Preoperative acid-reflux symptoms existed in 19.1% ± 15.1% of the patients. The risk of development of de novo GORD, oesophagitis, and BE after SG was 24.8% (95% CI 18.6-31.0%), 27.9% (95% CI 17.7-38.1%), and 6.7% (95% CI 3.7-9.7%), respectively. The between-study heterogeneity was significant in all outcome syntheses. It was suspected that several of the included studies have not reported BE and oesophagitis because such events might not have happened in their cohorts.
Long-term risk of de novo GORD after SG seems to be comparable with those of the general population which questions the merit of surveillance endoscopy after SG in asymptomatic patients. De novo BE and oesophagitis after SG have not been reported by most of the available studies which may lead to overestimation of the rates of both outcomes in any evidence synthesis. We recommend endoscopic surveillance for symptomatic patients only.
评估袖状胃切除术(SG)后长期新发酸反流相关并发症的发生率,以确定是否需要常规术后随访内镜检查。
系统检索了 Medline、Embase、CINAHL、CENTRAL、Web of Science 和参考文献列表。采用比例荟萃分析模型来量化 SG 后至少 4 年新发胃食管反流病(GORD)、食管炎和 Barrett 食管(BE)的风险。采用随机效应模型计算汇总结局数据。
共纳入 32 项观察性研究,报告了 7904 例接受初次 SG 并至少随访 4 年的患者。中位随访时间为 60 个月(48-132)。术前存在酸反流症状的患者占 19.1%±15.1%。SG 后新发 GORD、食管炎和 BE 的风险分别为 24.8%(95%CI 18.6-31.0%)、27.9%(95%CI 17.7-38.1%)和 6.7%(95%CI 3.7-9.7%)。所有结局综合分析均存在显著的研究间异质性。有理由怀疑,一些纳入的研究未报告 BE 和食管炎,因为这些事件可能并未发生在他们的队列中。
SG 后新发 GORD 的长期风险似乎与一般人群相当,这对无症状患者 SG 后进行内镜随访的价值提出了质疑。大多数现有研究并未报告 SG 后新发 BE 和食管炎,这可能导致任何证据综合分析中对这两种结局的发生率高估。我们建议仅对有症状的患者进行内镜监测。